;

Auto Summaries - Immunology
Last updated: 2021 Sep 7
Total hit(s): 7871
S.No.
1
34312570
A Unified Hierarchical XGBoost model for classifying priorities for COVID-19 vaccination campaign
The current ML approaches do not fully focus to answer a still unresolved and topical challenge, namely the prediction of priorities of COVID-19 vaccine administration. We measured the effectiveness of the proposed methodology for classifying all the priority classes while demonstrating a significant improvement with respect to the state of the art.
Pattern Recognit
2022 Jan
7.35
1
2
33857058
Needless COVID-19 Vaccine Fears: A Psychological Perspective
N/A
Psychiatr Danub
2021 Spring
0.835 (5 year)
1
3
33898648
Seroprevalence of SARS-CoV-2 Antibody in Echocardiography and Stress Laboratory
Assess the risk of transmission of past COVID-19 infection in echocardiography and stress laboratory staff.Determine whether or not to participate in a variety of procedures that may be aerosol-generating.
J Patient Cent Res Rev
2021 Spring
1
4
33220855
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Assess the safety and immunogenicity of a single-blind, randomised, controlled trial (COV002) in adults aged 70 years and older.Understand the effectiveness of a single-blind, randomised, controlled trial (COV002) in adults aged 18 years and older.Determine the coprimary outcomes of the trial.
Lancet
2021 Dec 19
43.38
26
5
33220853
Age and frailty in COVID-19 vaccine development
N/A
Lancet
2021 Dec 19
43.38
1
6
34124322
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
Understand the risks of cytokine storms in Covid-19 patients.Understand the benefits of Mesenchymal stem cells (MSCs).Use MSCs to reduce inflammatory cytokines, increase oxygen saturation and regenerate lung tissue.
Regen Ther
2021 Dec
1
7
34124327
An incentive-based approach may be the only approach to achieve COVID-19 herd immunity
N/A
Ethics Med Public Health
2021 Dec
0.27
1
8
33993845
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
Study the vaccines in vaccinated macaques.Determine whether prime-boost immunization with Sad23L-nCoV-S and Ad49L-nCoV-S is safe for both mice and macaques.
Emerg Microbes Infect
2021 Dec
5.84
2
9
34057040
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine
Observe the trend of neutralizing antibodies in individuals administered two doses of inactivated vaccine.
Emerg Microbes Infect
2021 Dec
5.84
1
10
34224330
Modulating the host immune response to fight against COVID-19: Where are we in 2021?
- Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
Virulence
2021 Dec
4.81
1
11
34308402
Case report of lymph node activation mimicking cancer progression: A false positive F(18) FDG PET CT after COVID-19 vaccination
This case illustrates a false positive F(18) FDG PET CT in the left axilla of a woman being treated for metastatic breast cancer after COVID-19 vaccination. Follow-up ultrasound of the axilla indicated no metastasis, indicating that the lymphadenopathy was likely due to an immune response following vaccination.
Curr Probl Cancer Case Rep
2021 Dec
1
12
34278956
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
Inactivated vaccines showed relatively lower level of neutralizing antibody and T cell responses, but a higher IgG2a/IgG1 ratio compared with other vaccines. Boosting with either recombinant subunit, adenovirus vectored or mRNA vaccine after two-doses of inactivated vaccine further improved immune responses. Our results provide new ideas for prophylactic inoculation strategy of SARS-CoV-2 vaccines.
Emerg Microbes Infect
2021 Dec
5.84
1
13
34092181
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants
Observe the neutralization of B.1, B.1.1.7, B.1.351, B.1.525 and P.1 lineages.
Emerg Microbes Infect
2021 Dec
5.84
1
14
33757410
Immune dysregulation and system pathology in COVID-19
Recognize that COVID-19 has caused a global public health crisis.Understand that COVID-19 is a dysregulated immune response.Recognize the recent therapeutic strategies in COVID-19.
Virulence
2021 Dec
4.81
1
15
34304724
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
K562-S cells can be propagated to a large scale by culturing and lose viability after exposure to X-ray irradiation or formalin. In mice, immunization with inactivated vaccines can elicit potent neutralizing antibody (nAb) responses persisting longer than 5 months. We showed in a hACE2 mouse model of SARS-CoV-2 infection that a two-shot vaccination with adjuvanted K62-S rendered greater than 3 log reduction in viral lung load and concomitant ameliorated lung pathology.
Emerg Microbes Infect
2021 Dec
5.84
1
16
34365904
Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice
The current COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has killed millions of people. Unfortunately, effective treatments for CoVs infection are still lacking, suggesting the importance of coronavirirus vaccines. Here, we show that N7-MTase of CoVs can be an ideal target for designing live attenuated vaccines.
Emerg Microbes Infect
2021 Dec
5.84
1
17
34306998
Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions
In a survey of older adults at higher risk for COVID-19 complications, we sought to describe expectations of trust in the safety and efficacy of a future vaccine. We also assessed whether these expectations were associated with known or suspected contributors to vaccine hesitancy, disparities in vaccine receipt, and potential targets for public health outreach.
Prev Med Rep
2021 Dec
3.8
1
18
33691606
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Use heterologous prime-boost vaccines.Use heterologous prime-boost vaccines to control the SARS-CoV-2 pandemic.
Emerg Microbes Infect
2021 Dec
5.84
1
19
33830901
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort
Monitor the immune response after SARS-CoV-2 infections.Analyze neutralizing antibodies and IgG responses.Consider correlating antibody signals to neutralizing titres.
Emerg Microbes Infect
2021 Dec
5.84
1
20
34003073
Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients
Identify immunogenic targets against the viral protein of SARS-CoV-2.Identify the major immunogenic epitopes from SARS-CoV-2.Identify the linear epitopes in vivo.
Emerg Microbes Infect
2021 Dec
5.84
1
21
33890550
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
Identify immunodominant sites within the RBD (RBD-ID) or all the 10 immunodominant sites within the RBD (RBD-ID).Determine whether the S-ID vaccine is effective against COVID-19.
Emerg Microbes Infect
2021 Dec
5.84
1
22
34251989
The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences
COVID-19 is a highly infectious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) The evaluation of clinical symptoms and laboratory findings from infected patients is critical for understanding the disease course and its consequences. In this review, we take a logical approach to unravel the reasons for immunodepression in patients with COID-19.
Virulence
2021 Dec
4.81
1
23
34125647
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
Identify natural SARS-CoV-2 infections in pets and canine species.Determine the seroprevalence of N- and RBD-specific antibodies in pet cats.Understand that SARS-CoV-2 seropositive rates are higher in pet cats than in MN early in the pandemic.
Virulence
2021 Dec
4.81
1
24
34110974
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution
Study the risk of SARS-CoV-2 infection in healthcare workers (HCW) nave for COVID-19 and seropositive after the second dose of the BNT162b2 mRNA vaccine.
Emerg Microbes Infect
2021 Dec
5.84
1
25
34002102
Global dynamics of SARS-CoV-2/cancer model with immune responses
Understand the symptoms of COVID-19.Construct a new SARS-CoV-2/cancer model.Determine the global stability of Lyapunov.Understand the role of lymphopenia in cancer patients.
Appl Math Comput
2021 Nov 1
1